Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Genetic study reveals shared pathways in OCD and tic disorders

7 September 2026 · By · Wire by Fusion42

Published

7 September 2026

Topic

opportunities

◆ Sectors

BiotechDrug Discovery

◆ Source

Read at drugdiscoverynews.com →

◆ Verified

Fusion42 · 7 September 2026 · Fusion42 review

An international study using whole-exome sequencing identified 36 genes linked to OCD and chronic tic disorders, revealing shared genetic pathways and neurobiological mechanisms behind both conditions.

This Wire brief sits within Fusion42's coverage of Biotech and Drug Discovery.

◆ ◆ The Wire takeaway

Biotech founders targeting OCD and tic disorders can now target a wider set of genes, creating new opportunities for innovative treatments and narrower patient stratification.

◆ Coverage

1 source · 7 Sep 2026

◆ Related on Wire

◆ Topics

BiotechDrug Discoveryocdtic-disordersgeneticsbiotechneurobiology